`
`
`
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`_______________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`_____________
`
`
`MYLAN TECHNOLOGIES, INC.
`Petitioner
`v.
`
`NOVEN PHARMACEUTICALS, INC.
`Patent Owner.
`
`_______________
`
`Case No. IPR2018-01119
`U.S. Patent No. 9,833,419
`____________________________________________________________
`
`
`NOVEN PHARMACEUTICALS, INC.’S
`FIRST UPDATED MANDATORY NOTICE
`UNDER 37 C.F.R. § 42.8
`
`
`
`
`
`4831-8567-6652.1
`
`
`
`
`
`U.S. Patent No. 9,833,419
`IPR2018-01119
`
`Pursuant to 37 C.F.R. § 42.8(a)(3), Petitioner Noven Pharmaceuticals
`
`(“Noven”) hereby files its first Updated Mandatory Notice:
`
`I.
`
`Related Matters Pursuant to 37 C.F.R. § 42.8 (b)(2):
`
`Noven hereby updates the initial Mandatory Notices filed June 7, 2018, to
`
`identify the following matters that may affect a decision in the instant proceeding:
`
`On June 12, 2018, the PTAB denied institution in IPR2018-00173, where
`
`the petition had challenged all claims of U.S. Patent No. 9,724,310 (“the ’310
`
`patent”). U.S. Patent No. 9,833,419 (“the ’419 patent”), which is the subject of the
`
`present proceeding, is a continuation of U.S. Patent Application No. 14/738,255,
`
`which is a continuation of U.S. Patent Application No. 14/024,985, which granted
`
`as the ’310 patent. Accordingly, the ’419 patent and the ’310 patent are related as
`
`part of the same continuity chain.
`
`Also on June 12, 2018, the PTAB denied institution in IPR2018-00174,
`
`where the petition had challenged all claims of U.S. Patent No. 9,730,900 (“the
`
`’900 patent”). The ’310 patent is a continuation of the ’900 patent. Accordingly,
`
`the ’419 patent and the ’900 patent are related as part of the same continuity chain
`
`as well.
`
`
`
`
`
`4831-8567-6652.1
`
`1
`
`
`
`Any questions concerning this paper may be directed to lead counsel.
`
`U.S. Patent No. 9,833,419
`IPR2018-01119
`
`
`
`
`
`
`
`
`
`
`Dated: June 28, 2018
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Respectfully submitted,
`
`/Courtenay C. Brinckerhoff/
`Courtenay C. Brinckerhoff
`Registration No. 37,288
`
`Jason N. Mock
`Registration No. 69,186
`
`Counsel for Patent Owner
`Foley & Lardner LLP
`
`4831-8567-6652.1
`
`2
`
`
`
`U.S. Patent No. 9,833,419
`IPR2018-01119
`
`CERTIFCATE OF SERVICE
`
`The undersigned hereby certifies that a copy of the foregoing Noven
`
`Pharmaceuticals, Inc.’s Updated Mandatory Notices Under 37 C.F.R. § 42.8
`
`was served on June 28, 2018, by email directed to the attorneys of record for the
`
`Petitioner at the following addresses:
`
`sparmelee@wsgr.com
`mrosato@wsgr.com
`jmills@wsgr.com
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`By: /Courtenay C. Brinckerhoff/
`Courtenay C. Brinckerhoff
`Registration No. 37,288
`
`Jason N. Mock
`Registration No. 69,186
`
`Counsel for Patent Owner
`Foley & Lardner LLP
`
`
`
`
`
`
`
`
`
`
`
`4831-8567-6652.1
`
`